HIGHLIGHTS
- who: Hanwen Zhang and collaborators from the Division of Radiological Chemistry, Department of Radiology, University Hospital Basel, Basel, Switzerland, Department of Radiology, Memorial Sloan-Kettering Cancer have published the research work: Evolution of Bombesin Conjugates for Targeted PET Imaging of Tumors, in the Journal: PLOS ONE | www.plosone.org of September/14,/2012
- what: This study provides a strong starting point for optimizing radiopeptides for targeting carcinomas that express any of the BN receptor subtypes. Together, the authors show these investigations play an important role towards optimizing radioligands for diagnosis and targeted radionuclide therapy of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.